You are viewing: Europe Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The Europe Long Read Sequencing Market was valued at $123.3 Million in 2024 and projected to reach to $526.3 Million by 2029, representing a compound annual growth rate of 33.7%. Europe's long read sequencing market is poised for exceptional growth, driven by increasing adoption in clinical laboratories, pharmaceutical R&D, and academic research institutions.

Europe Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Long Read Sequencing Market Trends and Insights

  • This represents a compound annual growth rate of 33.7%, reflecting strong adoption across European research institutions, clinical laboratories, and pharmaceutical companies.
  • Europe's advanced healthcare infrastructure, substantial R&D investments, and regulatory support for genomic medicine are driving accelerated market penetration throughout the forecast period. The European market benefits from established sequencing ecosystems, collaborative research networks, and increasing clinical applications in rare disease diagnosis and oncology.
  • Europe's commitment to precision medicine initiatives and genomic data sharing frameworks continues to create favorable conditions for long read sequencing technology deployment.
  • Between 2024 and 2029, Europe is expected to capture significant market share as healthcare providers increasingly recognize the diagnostic and therapeutic advantages of long read sequencing platforms..

Key Market Statistics

  • CAGR (2024-2029) 33.7% CAGR
  • Market Size, 2024 ~USD 123.3 Million
  • Forecast, 2029 ~USD 526.3 Million
  • Geography Europe

Europe Long Read Sequencing Market Overview

Market Valuation & Growth :

Europe's long read sequencing market is valued at $123.3 million in 2024, with a robust CAGR of 33.7% projected through 2029, reaching $526.3 million. This growth trajectory outpaces the global average of 32.8%, positioning Europe as a key growth driver.

Germany & UK Leadership :

Germany dominates the European market with $231 million in market size, followed by the UK at $212.7 million. These two countries represent over 35% of Europe's total long read sequencing market, driven by advanced research infrastructure and clinical adoption.

Advanced Healthcare Infrastructure :

Europe's strong healthcare systems, coupled with substantial R&D investments from pharmaceutical companies and research institutions, create an ideal environment for long read sequencing adoption across clinical diagnostics, genomic research, and precision medicine applications.

Emerging Market Opportunities :

France ($80.7M), Italy ($30.3M), and Spain ($18.0M) represent emerging growth opportunities within Europe. The 'Rest of Europe' segment contributes $123.9 million, indicating significant untapped potential across smaller European markets.

Europe Long Read Sequencing Market Dynamics

  • The region's commitment to genomic medicine, coupled with regulatory support for precision diagnostics, creates a favorable environment for market expansion.
  • Germany and the UK will continue to lead, while emerging markets across Southern and Eastern Europe present substantial growth opportunities. The forecast period (2024-2029) will witness accelerated technology adoption as costs decline and clinical applications expand.
  • European healthcare systems' emphasis on personalized medicine, combined with substantial government funding for genomic research initiatives, will sustain the 33.7% CAGR.
  • Strategic partnerships between sequencing providers and European research institutions will further catalyze market penetration and innovation..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Europe's long read sequencing market is valued at $123.3 million in 2024 and will grow to $526.3 million by 2029, representing a 33.7% CAGR.
    • Europe's advanced healthcare infrastructure and regulatory frameworks are accelerating adoption of long read sequencing across clinical and research settings.
    • Precision medicine initiatives and genomic data sharing programs throughout Europe are creating sustained demand for long read sequencing technologies.
    • Europe's market growth is driven by increasing applications in rare disease diagnosis, oncology, and personalized medicine between 2024 and 2029.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    Europe Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    EUROPE: LONG-READ SEQUENCING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTE61.482.6105.6137180.5240.2322.4449.433.6
    HOSPITALS, CLINICS, AND DIAGNOSTIC LABS19.22633.543.858.177.8105.2147.634.5
    OTHER END USER10131619.925.232.141.254.928
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES2837.64862.181.7108.5145.5202.533.4
    TOTAL118.6159.2203.1262.9345.4458.7614.2854.433.3

    REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTE14.219.124.531.8425675.3105.233.8
    HOSPITALS, CLINICS, AND DIAGNOSTIC LABS4.66.2810.513.918.625.235.434.6
    OTHER END USER2.22.93.54.45.67.19.112.228.1
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES6.48.61114.218.724.933.546.733.6
    TOTAL27.336.84760.980.2106.7143.1199.433.5

    Target Audience

    • Sequencing Technology Manufacturers : Manufacturers of long read sequencing platforms need Europe-specific market data to optimize product development, pricing strategies, and go-to-market approaches. Understanding regional adoption patterns and competitive dynamics is critical for capturing market share in this high-growth region.
    • Clinical Laboratory Operators : European clinical laboratories require market intelligence to evaluate long read sequencing adoption, assess competitive offerings, and plan capital investments. Country-level data helps identify best practices and benchmark performance against regional peers.
    • Pharmaceutical & Biotech Companies : Pharma and biotech firms conducting genomic research in Europe need detailed market insights to guide R&D investments, identify collaboration opportunities, and understand the competitive landscape for precision medicine applications across different European markets.
    • Healthcare Investors & Consultants : Investment firms and management consultants require comprehensive European market data to evaluate investment opportunities, assess market valuations, and develop growth strategies for long read sequencing companies operating in or targeting the European region.
    • Research Institutions & Academic Centers : European research institutions and academic medical centers need market data to understand technology trends, identify funding opportunities, and benchmark their genomic research capabilities against regional and global standards in long read sequencing.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 779 Million · 33.1% wtd CAGR ·
    Asia Pacific
    ~USD 450.4 Million · 34.9% wtd CAGR ·
    Latin America
    ~USD 86.8 Million · 29.9% wtd CAGR ·
    Middle East
    ~USD 73.3 Million · 27.6% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 231 Million
    UKUSD 212.7 Million
    FranceUSD 80.7 Million
    ItalyUSD 30.3 Million
    SpainUSD 18 Million
    Rest Of EuropeUSD 123.9 Million

    Country market size visualization

    Germany
    USD 231 Million
    UK
    USD 212.7 Million
    France
    USD 80.7 Million
    Italy
    USD 30.3 Million
    Spain
    USD 18 Million
    Rest Of Europe
    USD 123.9 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into Europe's long read sequencing market with country-level breakdowns for Germany, UK, France, Italy, Spain, and Rest of Europe. Understand regional variations in adoption rates, regulatory environments, and growth drivers specific to each market.
    • Competitive Landscape Analysis : Identify leading sequencing technology providers, clinical laboratory operators, and research institutions across Europe. Understand competitive positioning, market share distribution, and strategic partnerships shaping the European market dynamics.
    • Growth Opportunity Mapping : Discover high-potential segments within Europe including clinical diagnostics, oncology research, infectious disease detection, and rare disease identification. Pinpoint emerging markets and underserved regions for expansion and investment opportunities.
    • Regulatory & Reimbursement Insights : Navigate Europe's complex regulatory landscape including CE marking requirements, GDPR compliance, and country-specific reimbursement policies. Understand how regulatory frameworks impact market adoption and pricing strategies across different European markets.
    • Strategic Decision Support : Make informed decisions on market entry, partnership development, and product positioning in Europe. Leverage comprehensive market data, trend analysis, and forecasts to align business strategies with regional growth opportunities and customer needs.

    Frequently asked questions

    What is the current size of Europe's long read sequencing market?

    Europe's long read sequencing market was valued at $123.3 million in 2024 and is projected to reach $526.3 million by 2029.

    What is the expected growth rate for long read sequencing in Europe?

    Europe's long read sequencing market is expected to grow at a compound annual growth rate (CAGR) of 33.7% from 2024 to 2029.

    Which factors are driving Europe's long read sequencing market growth?

    Europe's market growth is driven by advanced healthcare infrastructure, precision medicine initiatives, regulatory support for genomic medicine, and increasing clinical applications in rare disease diagnosis and oncology.

    What are the primary applications of long read sequencing in Europe?

    In Europe, long read sequencing is primarily applied in rare disease diagnosis, oncology, personalized medicine, and genomic research across clinical laboratories and research institutions.

    How does Europe's long read sequencing market compare to global trends?

    Europe's 33.7% CAGR slightly exceeds the global average of 32.8%, indicating stronger regional adoption and market maturity in European healthcare systems.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status